NCT06674304Active, not recruiting
Registry Initiative Across Borders for Atrial Fibrillation in Africa
Source: ClinicalTrials.gov · Last updated 6 Nov 2024
Brief summary (registry, in English)
Atrial fibrillation is a penalizing disease in several ways: morbidity and mortality, health costs. Several multicenter registries have been published. Until now, no multicenter registry involving several countries has been carried out in Africa. The goal of RIBAT AF Africa is to fill this gap, by recruting patients from twelve african centers. All the centers are a third level Atrial Fibrillation managment facility centers. After recruitment , a complete clinical assessment with analysis of comorbidities will be a priority of this registry to try to understand the epidemiological profile of atrial fibrillation in Africa. Then, we will proceed to the temporal classification of atrial fibrillation according to the 2024 ESC recommendations (type and thromboembolic risk in particular.). After this step, the management will be analyzed with three main axes: management of comorbidities, antithrombotic treatment, rhythm and frequency control. Some therapeutic techniques such as ablation of atrial fibrillation were discussed without much detail because many countries do not yet have access to these expensive techniques. A six-month evaluation is necessary to judge above all the applicability of the measures accessible in all countries and in particular anticoagulant treatment. All these data will be recorded anonymously and electronically. Each country can have access to its own data anytime. The statistical analysis will be carried out by a team within the University Hospital of Tangier , as well as all IT logistics. This team will also organize electronic monitoring and underlying all abnomalities in CRF.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 3 Nov 2024
- Start date
- 22 Oct 2024
- Primary completion date
- May 2025
- Lead sponsor
- Mohammed VI University Hospital
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT06674304
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 22 Oct 2024 to the primary completion date, May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No formal diagnosis of AF in medical records
- Only atrial flutter or other atrial tachycardia diagnosed
- Participation in a clinical trial (but participation in another registry is allowed)
Who the study is looking for
- Patients aged ≥ 18 years old
- Patients with a documented history of AF for any length of time before enrolment or AF first diagnosed at enrolment visit/hospitalization
- Patients previously diagnosed with AF must have at least one documented visit or hospitalization for AF (or AF-related complications) within the last 12 months before enrolment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mohammed VI University Hospital of Tangier Coordinator of this site? Confirm its status | Tangier | Morocco | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.